Contact Us
Drug Search Results
More Filters [+]

Artemisinin

Alternative Names: artemisinin, coartem
Latest Update: 2025-01-16
Latest Update Note: Clinical Trial Update

Product Description

Artemisinins are derived from extracts of sweet wormwood (Artemisia annua) and are well established for the treatment of malaria, including highly drug-resistant strains. (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758403/)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Brazil | China | Colombia | Dominican Republic | Indonesia | Pakistan | Peru | South Africa | Thailand | United States | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Novartis
Company Location: BASEL V8 CH 4056
Company CEO: Vasant Narasimhan
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Artemisinin

Countries in Clinic: Burkina Faso, China, Gabon, Ghana, Kenya, Uganda, United States, Unknown Location

Active Clinical Trial Count: 4

Highest Development Phases

Phase 2: Cervical Cancer|Malaria, Falciparum|Papillomavirus Infections|Uterine Cancer|Uterine Cervical Dysplasia

Phase 1: Malaria, Vivax

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
PLATINUM

P2

Recruiting

Malaria, Falciparum

2026-06-05

CHMI-TransMod

P2

Suspended

Malaria, Falciparum

2025-12-01

ART-CIN_IIB

P2

Recruiting

Uterine Cervical Dysplasia|Cervical Cancer|Uterine Cancer|Papillomavirus Infections

2025-07-31

CTR20242902

P1

Recruiting

Malaria, Falciparum|Malaria, Vivax

None

Recent News Events

Date

Type

Title

12/03/2024

News Article

 Botanical and Plant-Derived Drugs Market to grow by USD 20.93 Billion (2024-2028), driven by government initiatives, with AI powering market evolution - Technavio

12/02/2024

News Article

 Active Pharmaceutical Ingredients Market to Grow by USD 86.47 Billion (2024-2028), Driven by Evolving API Manufacturing, with AI Driving Market Transformation - Technavio

07/05/2024

News Article

 Nominations Open for the Prestigious Tu Youyou Award 2024

04/26/2024

News Article

 Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions